Diagnosis of biliary tract and ampullary carcinomas

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 15, Issue 1, 2008, Pages 31-40

  Tsukada, Kazuhiro ^a   Takada, Tadahiro ^b   Miyazaki, Masaru ^c   Miyakawa, Shuichi ^d   Nagino, Masato ^e   Kondo, Satoshi ^f   Furuse, Junji ^g   Saito, Hiroya ^h   Tsuyuguchi, Toshio ^c   Kimura, Fumio ^c   Yoshitomi, Hideyuki ^c   Nozawa, Satoshi ^c   Yoshida, Masahiro ^b   Wada, Keita ^b   Amano, Hodaka ^b   Miura, Fumihiko ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^h Asahikawa Kosei Hospital   (Japan)

Author keywords

Biliary tract neoplasm; Endoscopic ultrasonography (EUS); Guidelines; Multidetector computed tomography (MDCT)

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ABDOMINAL PAIN; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT ENDOSCOPY; BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; ECHOGRAPHY; FEVER; GALLBLADDER CANCER; HEPATOBILIARY SYSTEM; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE MEASUREMENT; OBSTRUCTIVE JAUNDICE; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; RISK FACTOR; SYMPTOM; TUMOR BIOPSY; VATER PAPILLA CARCINOMA;

AMPULLA OF VATER; BILIARY TRACT NEOPLASMS; CARCINOMA; ENDOSCOPY, DIGESTIVE SYSTEM; EVIDENCE-BASED MEDICINE; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 39549092400     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-007-1278-6     Document Type: Article

References (70)

1. Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:2-6.
2. Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin N Am 1990;70:1429-47.
3. Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: A review. Gastroenterologist 1997;5:306-15.
4. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128:1655-67.
5. Sugiyama M, Atomi Y, Kuroda A, Muto T. Bile duct carcinoma without jaundice: Clues to early diagnosis. Hepatogastroenterology 1997;44:1477-83.
6. Wanebo HJ, Castle WN, Fechner RE. Is carcinoma of the gallbladder a curable lesion? Ann Surg 1982;195:624-31.
7. Malik IA. Clinicopathological features and management of gallbladder cancer in Pakistan: A prospective study of 233 cases. J Gastroenterol Hepatol 2003;18:950-3.
8. Al-Quadah MS, Daradkeh S, Sroujieh AS, Farah GR, Masaad J. Gallbladder carcinoma in Jordan. Hepatogastroenterology 2005; 61:5-7.
9. Trede M. Periampullary and pancreatic cancer. In: Blumgart LH, editor. Surgery of the liver and biliary tract. 2 nd ed. New York: Churchill Livingstone; 1994. p. 997-1008.
10. Dijkum EJMN, Terwee CB, Oosterveld P, Meulen JHP, Gouma DJ, Haes JCJM. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma. Br J Surg 2000;87:110-5.
11. Kamisawa T, Tu Y, Egawa N, Nakajima H, Horiguchi S, Tsuruta K, Okamoto A. Clinicopathologic features of ampullary carcinoma without jaundice. J Clin Gastroenterol 2006;40:162-6.
12. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. New Engl J Med 1999;341:1368-79.
13. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366:1303-14.
14. Robledo R, Muro A, Prieto ML. Extrahepatic bile duct carcinoma. US characteristics and accuracy in demonstration of tumors. Radiology 1996;198:869-73.
15. Choi BL, Lee JH, Han MC, Kim SH, Yi JG, Kim CW. Hilar cholangiocarcinoma: Comparative study with sonography and CT. Radiology 1989;172:689-92.
16. Lillemoe KD. Tumors of the gallbladder, bile duct, and ampulla. Semin Gastrointest Dis 2003;14:208-21.
17. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167-76.
18. Piantino P, Fusaro A, Randone A, Cerchier A, Daziano E. Increased levels of CA19-9, CA50 and CA125 in patients with benign disease of biliary tract and the pancreas. J Nucl Med Allied Sci 1990;34:97-102.
19. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-7.
20. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874-9.
21. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al.; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51:1-9.
22. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E. Clinical value of serum tumor markers CEA, CA50 and CA242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis: Results from a prospective study. Anticancer Res 1992;12:1687-93.
23. Vij U, Baskaran V. Value of serum CEA and AFP in the diagnosis and prognosis of carcinoma gallbladder. Trop Gastroenterol 2001;22:227-9.
24. Chaube A, Tewari M, Singh U, Shukla HS. CA 125: A potential tumor marker for gallbladder cancer. J Surg Oncol 2006;93:665-9.
25. Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, Kim SW. Cholangiocarcinoma: Pictorial essay of CT and cholangiographic findings. Radiographics 2002;22:173-87.
26. Chen HW, Pan AZ, Zhen ZJ, Su SY, Wang JH, Yu SC, Lau WY. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography. AJR Am J Roentgenol 2006;186:1580-6.
27. Campbell WL, Peterson MS, Federle MP, Siqueira ES, Slivka A, Grazioli L, et al. Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis. AJR Am J Roentgenol 2001;177:1095-100.
28. Johnson KJ, Olliff JF, Olliff SP. The presence and significance of lymphadenopathy detected by CT in primary sclerosing cholangitis. Br J Radiol 1998;71:1279-82.
29. Noji T, Kondo S, Hirano S, Tanaka E, Ambo Y, Kawarada Y, Morikawa T. CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol 2005;40:739-43.
30. Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, Clavien PA. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006;45:43-50.
31. Lopera JE, Soto JA, Munera F. Malignant hilar and perihilar biliary obstruction: Use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology 2001;220:90-6.
32. Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: A meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003;139:547-57.
33. Barish MA, Yocel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. New Engl J Med 1999;341:258-64.
34. Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004;233:234-40.
35. Figueras J, Llado L, Valls C, Serrano T, Ramos E, Fabregat J, et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 2000;6:786-94.
36. Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: A histologic analysis of 62 resected cases. Ann Surg 1998;227:405-11.
37. Hayashi S, Miyazaki M, Kondo Y, Nakajima N. Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases. Cancer 1994;73:2922-9.
38. Nimura Y, Kamiya J, Hayakawa N, Shionoya S. Cholangioscopic differentiation of biliary strictures and polyps. Endoscopy 1989;21 Suppl 1:351-6.
39. Nimura Y. Staging of biliary carcinoma: Cholangiography and cholangioscopy. Endoscopy 1993;25:76-80.
40. Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc 2007;66:730-6.
41. Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc 2005;62:374-82.
42. Tamada K, Ido K, Ueno N, Ichiyama M, Tomiyama T, Nishizono T, et al. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995;27:579-83.
43. Tamada K, Nagai H, Yasuda Y, Tomiyama T, Ohashi A, Wada S, et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 2001;53:300-7.
44. Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [(18)F] fluoro-2-deoxy-D glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029-35.
45. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004;8:90-7.
46. Cullen SN, Chapman RW. Current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 2005;21:933-48.
47. Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gallbladder lesions: Analysis in surgical and follow up series. Gut 2000;46:250-4.
48. Azuma T, Yoshikawa T, Araida T, Takasaki K. Differential diagnosis of polypoid lesion of the gallbladder by endoscopic ultrasonography. Am J Surg 2001;181:65-70.
49. Hirooka Y, Naitoh Y, Goto H, Ito A, Hayakawa S, Watanabe Y, et al. Contrast-enhanced endoscopic ultrasonography in gallbladder diseases. Gastrointest Endosc 1998;48:406-10.
50. Sadamoto Y, Kubo H, Harada N, Tanaka M, Eguchi T, Hawata H. Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc 2003;58:536-41.
51. Furukawa H, Kosuge T, Shimada K, Yamamoto J, Kanai Y, Mukai K, et al. Small polypoid lesions of the gallbladder. Arch Surg 1998;133:735-9.
52. Yoshimitsu K, Honda H, Shinozaki K, Aibe H, Kuroiwa T, Irie H, et al. Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol 2002; 179:423-8.
53. Ohtani T, Shirai Y, Tsukada K, Muto T, Hatakeyama K. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging 1996;21:195-201.
54. Engels JT, Balfe DM, Lee JKT. Biliary carcinoma: CT evaluation of extrahepatic spread. Radiology 1989;172:35-40.
55. Ohtani T, Shirai Y, Tsukada K. Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology 1993;189:875-80.
56. Kumaran V, Gulati S, Paul B, Pande GK, Sahni P, Chattopadhyay TK. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol 2002;12:1993-9.
57. Kaneoka Y, Yamaguchi A, Isogai M, Harada T, Suzuki M. Hepatoduodenal ligament invasion by gallbladder carcinoma: Histologic pattern and surgical recommendation. World J Surg 2003;27:260-5.
58. Nakata T, Kobayashi A, Miwa S, Soeda J, Miyagawa S. Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma World J Surg 2007;31:155-61.
59. Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: A comprehesive update, part 1. Oncology 2004;18:889-96.
60. Verma K, Bhargava DK. Cytologic examination as an adjunct to laparoscopy and guided biopsy in the diagnosis of hepatic and gallbladder neoplasia. Acta Cytol 1982;26:311-6.
61. Ishikawa O, Ohhigashi H, Sasaki Y, Imaoka T, Wada A, Ishiguro S, et al. The usefulness of saline irrigated bile for the intraoperative cytologic diagnosis of tumors and tumorlike lesions of the gallbladder. Acta Cytol 1988;32:475-81.
62. Akosa AB, Barker F, Desa L, Benjamin I, Krausz T. Cytologic diagnosis in the management of gallbladder carcinoma. Acta Cytol 1995;39:494-8.
63. Kim JH, Kim TK, Eun HW. Preoperative evaluation of gallbladder carcinoma: Efficacy of combined use of MR imaging, MR cholangigraphy, and contrast-enhanced dual phase three dimensional MR angiography. J Magn Reson Imaging 2002;16:676-84.
64. Schwartz LH, Black J, Fong, Jarnagin W, Blumgart L, Gruen D, et al. Gallbladder carcinoma: Findings at MR imaging with MR cholangiopancreatography 2002;26:405-10.
65. Futakawa N, Kimura W, Wada Y, Muto T. Clinicopathological characteristics and surgical procedures for carcinoma of the papilla of Vater. Hepatogastroenterology 1996;43:260-7.
66. Mortele JK, Ji H, Ros PR. CT and magnetic resonance imaging in pancreatic and biliary tract malignancies. Gastrointest Endosc 2002;56:206-12.
67. Yamaguchi K, Enjoji M, Kitamura K. Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 1990;36:588-92.
68. Bohnacker S, Soehendra N, Maguchi H, Chung JB, Howell DA. Endoscopic resection of benign tumors of the papilla of Vater. Endoscopy 2006;38:521-5.
69. Menzel J, Hoepffner N, Sulkowski U, Reimer P, Heinecke A, Poremba C, Domschke W. Polypoid tumors of the major duodenal papilla: Preoperative staging with intraductal US, EUS, and CT-a prospective, histopathologically controlled study. Gastrointest Endosc 1999;49:349-57.
70. Itoh A, Goto H, Naitoh Y, Hirooka Y, Furukawa T, Hayakawa T. Intraductal ultrasonography in diagnosing tumor extension of cancer of the papilla of Vater. Gastrointest Endosc 1997;45:251-60.